Evidence map›Paper›PMID 38611524›Full record

ArticlePlants (Basel, Switzerland)2024

The Antimicrobial Effects of Myrosinase Hydrolysis Products Derived from Glucosinolates Isolated from

Zoltán Polozsányi, Helena Galádová, Michal Kaliňák, Martin Jopčík, Barbora Kaliňáková, Albert Breier, Martin Šimkovič

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Plants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zoltán PolozsányiInstitute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.ORCID 0000-0002-2747-6653
Helena GaládováInstitute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.
Michal KaliňákCentral Laboratories, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.ORCID 0000-0003-0091-9140
Martin JopčíkInstitute of Plant Genetics and Biotechnology, Plant Science and Biodiversity Center, Slovak Academy of Sciences, Akademická 969, 949 01 Nitra, Slovakia.
Barbora KaliňákováInstitute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.
Albert BreierInstitute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.ORCID 0000-0003-2174-786X
Martin ŠimkovičInstitute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.ORCID 0000-0002-6497-1899
Slovak University of Technology in Bratislava · SKSlovak Academy of Sciences · SK

Funding

Slovak Agency for Research and Development APVV-22-0383, APVV-19-0094State program of research and development of Slovak Republic 2003SP200280203Structural funds of European Union ITMS 26230120009
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobial activityglucoraphaninLepidium drabamyrosinase (β-thioglucosidase, EC 3.2.1.147)sinalbin

Identifiers

PMID38611524
PMCPMC11013450
OpenAlexW4393378124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.